Bl. Mcvicker et al., Hyperphosphorylation of the asialoglycoprotein receptor in isolated rat hepatocytes following ethanol administration, BIOCH PHARM, 60(3), 2000, pp. 343-351
Ethanol administration leads to altered function and impaired receptor-medi
ated endocytosis of the hepatocyte asialoglycoprotein receptor (ASGP-R). Th
e purpose of the present study was to examine the effects of ethanol on the
phosphorylation of the ASGP-R to determine whether this post-translational
modification could contribute mechanistically to the observed ethanol-indu
ced alterations. The methodological approach of this work involved the meas
urement of the phosphorylation state of the receptor obtained from isolated
rat hepatocytes, using a combination of experimental designs from the bios
ynthetic incorporation of phosphate to the determination of steady-state ph
osphotyrosine levels. We report here that both short-term (1- to 2-week) an
d chronic (5- to 7-week) periods of ethanol administration resulted in a si
gnificant increase in the steady-state phosphotyrosine protein in the ASGP-
R. In addition, in vitro incorporation of [gamma-P-32]ATP using a permeabil
ized cell assay system similarly showed an increase in tyrosine-phosphoryla
ted receptors. Furthermore, metabolic radiolabeling of hepatocytes with [P-
32]orthophosphate demonstrated hyperphosphorylation of the ASGP-R in cells
obtained from chronically ethanol-fed animals. Finally, our results reveale
d that dephosphorylation of the ASGP-R was unaffected by ethanol administra
tion, indicating that kinase activity rather than impaired phosphatase acti
on contributes to the increased phosphorylation state of the receptor. Over
all, the results presented in this study demonstrated that the extent of ty
rosine phosphorylation of the receptor is significantly higher in hepatocyt
es obtained from ethanol-fed animals. We conclude that hyperphosphorylation
of the ASGP-R may be a contributing factor to the impaired function of the
receptor elicited by ethanol administration. BIOCHEM PHARMACOL 60;3:343-35
1, 2000. (C) 2000 Elsevier Science Inc.